Направо към основното съдържание
Лого
Accelerating Clinical Trials in the EU

ACT EU workplan for 2025-2026 published

  • Новинарска статия
  • 20 Януари 2025 г.
  • Европейска агенция по лекарствата
  • Време за четене 1 мин

The ACT EU workplan for 2025-2026 is now available. 

The revised workplan highlights ACT EU’s areas of focus over the next two years, reflecting the feedback received through the multi-stakeholder platform advisory group and other channels: 

  • The operation of the Clinical Trials Regulation.
  • Maximising the impact of clinical trials.
  • Clinical trials in public health emergencies.

Clinical trial analytics, training, and communication remain integral to ACT EU’s work, and interlinked with all other activities. 

For more details, see: ACT EU workplan 2025-2026

Дата на публикуване
20 Януари 2025 г.
Автор
Европейска агенция по лекарствата